Nam Hyo Kim is an Assistant Scientist in the Social Administrative Sciences at the University of Wisconsin-Madison School of Pharmacy. Her research interest is evaluating impacts of health care policy on health care utilization and outcomes. One crucial component of the health care policy is prescription drug insurance coverage. With her pharmacy background, she is particularly interested in drug insurance benefit designs and their effects on access to medications and other related health services. Her research pursue finding empirical evidence on the impacts of drug insurance coverage focusing on recent health policy changes in the U.S. The goal of her research is to provide scientific evidence to allow policy makers to design effective health policies for enhancing public health. 

She has evaluated the effects of two provisions in the Affordable Care Act; the dependent coverage mandate and the contraceptive methods coverage requirement in private health insurance. Her recent research interest is access to medications among low-income patients; she is currently studying the impacts of changing prescription drug coverage in Wisconsin’s Medicaid program for low-income childless adults. She is also actively working on the evaluation of Wisconsin SeniorCare, a state pharmaceutical assistance program for low-income seniors. 

Nam Hyo Kim received her PhD degree in Social & Administrative Sciences from University of Wisconsin-Madison, School of Pharmacy. Her graduate training focuses on health service research in pharmacy and public health by using secondary data analysis methods and quasi-experimental research designs. She is also trained for applying health economics to public policy analysis.

PhD in Social and Administrative Sciences in Pharmacy (2018) - University of Wisconsin-Madison

MS in Therapeutic Pharmacy (2011) - Sookmyung Women's University (Seoul, Korea)

BS in Pharmacy (2009) - Sookmyung Women's University (Seoul, Korea)

Guest lecturer 

1. Medical College of Wisconsin, School of Pharmacy 

PHAR 550 Health Care Systems Patient Safety

"Basics of health insurance and public health insurance in the U.S."

2. University of Wisconsin-Madison, School of Pharmacy 

SA PHM 411 The role of the pharmacist in the public health system

"International Healthcare Services"

Teaching assistant 

1. University of Wisconsin-Madison, School of Pharmacy

S&A PHM 411, The role of the pharmacist in the public health system

PHM 608, Safety and quality in the medication use system

S&A PHM 618, Professional decision-making in pharmacy practice

2. Sookmyung Women's University, School of Pharmacy

Lab in Pharmacy Practice

1. Kim NH, Look KA. The impact of reduced drug copayments on adherence to oral diabetes medications among childless adults in Wisconsin Medicaid. Journal of Managed Care & Specialty Pharmacy. 2019 Dec;25(12):1432-1441. doi: 10.18553/jmcp.2019.25.12.1432.

2. Kim NH, Look KA, Burns ME. Low-income childless adults’ access to antidiabetic drugs in Wisconsin Medicaid after coverage expansion. Health Affairs (Millwood). 2019;38(7):1145–1152. doi: 10.1377/hlthaff.2018.05198.

3. Kim NH, Look KA. Effects of the Affordable Care Act’s contraceptive coverage requirement on the utilization and out-of-pocket costs of prescribed oral contraceptives. Res Social Adm Pharm. 2018;14(5):479-487. doi: 10.1016/j.sapharm.2017.06.005.  

4. Look KA, Kim NH, Arora P. Effects of the Affordable Care Act’s dependent coverage mandate on private health insurance coverage in urban and rural areas. J Rural Health. 2017; 33(1):5-11. doi: 10.1111/jrh.12183.

5. Park C, Kim NH, Shin DY, Feldman SR, Balkrishnan R, Chang J. The association of physicians’ caring attitude with patient satisfaction: an analysis of the National e-survey data. Korean Journal of Hospital Management. 2015;20(2):15-27.

6. Kim NH, Choi KE, Sohn HS, Shin IC, Shin HT. The effect of tiered copayment system on pharmacy benefit expenditure of National Health Insurance in Korea: scenario analysis based on the use of oral antidiabetic medications. Korean Journal of Clinical Pharmacy. 2014; 24(2): 126-134.

7. Choi KE, Sohn HS, Kim NH, Shin HT, Lee YS. Therapeutic duplication criteria development of respiratory system drugs. Yakhak Hoeji. 2012; 56(2): 126-135.

8. Lee YS, Kim NH, Sohn HS, Choi KE, Shin HT. Development of drug utilization review guidelines for therapeutic duplication of antipyretics, analgesics, and anti-inflammatory drugs registered in Korea. Korean Journal of Clinical Pharmacy. 2010; 20(3): 213-220.